Raul Rabadan

Raul Rabadan

Titles

Professor, Department of Systems Biology

Affiliations

Department of Systems Biology
Department of Biomedical Informatics
Center for Computational Biology and Bioinformatics
Center for Cancer Systems Therapeutics
JP Sulzberger Columbia Genome Center

Phone

(212) 851-5141

Raul Rabadan is a Professor in the Department of Systems Biology, with a joint appointment in Biomedical Informatics. He is the director of the Center for Topology of Cancer Evolution and Heterogeneity. From 2001 to 2003, Dr. Rabadan was a fellow at the Theoretical Physics Division at CERN, the European Organization for Nuclear Research, in Geneva, Switzerland. In 2003 he joined the Physics Group of the School of Natural Sciences at the Institute for Advanced Study. Previously, Dr. Rabadan was the Martin A. and Helen Chooljian Member at The Simons Center for Systems Biology at the Institute for Advanced Study in Princeton, New Jersey. He has been named one of Popular Science's Brilliant 10 (2010), a Stewart Trust Fellow (2013), and he received the Harold and Golden Lamport Award at Columbia University (2014). Dr. Rabadan’s current interest focuses on uncovering patterns of evolution in biological systems—in particular, RNA viruses and cancer.

More News

News

It’s All In the Math: New Tool Provides Roadmap for Cell Development
Researchers at Columbia University Medical Center have created a new tool to describe the many possible ways in which a cell may develop. Rooted in the mathematical field of topology, the tool provides a roadmap that offers detailed insight into how stem cells give rise to specialized cells.
Columbia Awarded NCI Center for Cancer Systems Biology
The Center for Cancer Systems Therapeutics (CaST) is developing a framework that can account for the dynamic nature of cancer and use this knowledge to disrupt the programs that maintain tumor survival.
Study of Glioblastoma Tumor Evolution Reveals Strategies Against Advanced Disease
Genetically distinct populations of cells appear to drive malignancy before and after therapy. The findings provide insights into GBM drug resistance and how it might be overcome.
Graduate Students Invent Technique for Reprogramming Translation
MD/PhD students Andrew Anzalone and Sakellarios Zairis engineered RNA motifs capable of inducing ribosomal frameshifting. Their method could offer new opportunities for synthetic biology.
Columbia Investigators Awarded New NCI Physical Sciences in Oncology Center
The Center for Topology of Cancer Evolution and Heterogeneity will combine new mathematical approaches and single-cell experimental technologies to study cellular diversity in solid tumors.